Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Achillion Pharmaceuticals hired David Apelian as executive vp and chief medical officer. Most recently, he was sr vp of R&D and chief medical officer at GlobeImmune. Before that, Apelian was clinical director in the infectious diseases group at Bristol-Myers Squibb and clinical director in the department of hepatology and gastroenterology at Schering Plough.
Generic Pharmaceutical Association promoted Jason Money to assoc vp, federal gov’t affairs;
AbbVie says chief scientist John Leonard is retiring;
Breast Cancer Action says former executive director Barbara Brenner passed away;
American Psychiatric Association named Saul Levin as ceo and medical director;
Achillion Pharmaceuticals hired Kevin Kucharski as sr vp of clinical operations;
Zosano Pharma hired Nandan Oza as chief operations officer;
Vivus added J. Martin Carroll to its board;
Vivus added Jorge Plutzky to its board;
Optimer Pharmaceuticals named Eric Sirota as chief operating officer;
Bayer AG hired Herbert Heitmann to head communications and government relations;
Harvard Bioscience says ceo Chane Graziano is retiring;
Harvard Bioscience named David Green as interim ceo;
Durata Therapeutics added Paul Friedman to its board;
LIST ENDS HERE